Download PDF
Dtsch Med Wochenschr 2015; 140(23): 1741-1746
DOI: 10.1055/s-0041-104814
Dossier
Kardiale OP-Indikationen
© Georg Thieme Verlag KG Stuttgart · New York

Stabile koronare Herzkrankheit – wann operieren?

Stable coronary heart disease – when is bypass surgery appropriate?
Udo Sechtem
1   Abteilung für Kardiologie, Robert-Bosch-Krankenhaus Stuttgart
,
Ulrich Franke
2   Abteilung für Herz- und Gefäßchirurgie, Robert-Bosch-Krankenhaus Stuttgart
› Author Affiliations
Further Information

Publication History

Publication Date:
19 November 2015 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Die medikamentöse Therapie hat bei der stabilen koronaren Herzkrankheit (KHK) einen zentrale Stellenwert. Obwohl viele Patienten zusätzlich mit Katheter-Intervention (PCI) behandelt werden, bleibt die Bypassoperation eine wichtige Therapieoption. Bei komplexer koronarer Anatomie verbessert die Bypassoperation die Prognose der Patienten im Vergleich zur PCI. Moderne Techniken haben die Invasivität des chirurgischen Eingriffs deutlich verringert.

Abstract

Medical treatment is the therapeutic cornerstone in patients with stable coronary artery disease (SCAD). Although an increasing number of these patients is treated with percutaneous interventions (PCI), bypass surgery remains an important therapeutic option. Bypass surgery improves the prognosis of patients with complex coronary anatomy as compared to PCI. Modern surgical techniques lead to a considerable reduction of the invasiveness of the operation.

Schlüsselwörter

stabile koronare Herzerkrankung - medikamentöse Therapie - PCI - Bypasschirurgie

Keywords

stable coronary artery disease - medical therapy - PCI - bypass surgery
 

  • Literatur

  • 1 Iqbal J, Zhang YJ, Holmes DR et al. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation 2015; 131: 1269-1277
    CrossrefPubMedGoogle Scholar
  • 2 The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013; 34: 2949-3003
    CrossrefPubMedGoogle Scholar
  • 3 Yeh RW, Mauri L, Wolf RE et al. Population trends in rates of coronary revascularization. JAMA Intern Med 2015; 175: 454-456
    CrossrefPubMedGoogle Scholar
  • 4 Ford ES, Ajani UA, Croft JB et al. Explaining the decrease in U. S. deaths from coronary disease, 1980–2000. N Engl J Med 2007; 356: 2388-2398
    CrossrefPubMedGoogle Scholar
  • 5 Boden WE, O‘Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516
    CrossrefPubMedGoogle Scholar
  • 6 Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF / SCAI / STS / AATS / AHA / ASNC / HFSA / SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2012; 59: 857-881
    CrossrefPubMedGoogle Scholar
  • 7 Weintraub WS, Spertus JA, Kolm P et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008; 359: 677-687
    CrossrefPubMedGoogle Scholar
  • 8 European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2: 1173-1180
    PubMedGoogle Scholar
  • 9 CASS Principal Investigators and Their Associates. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N Engl J Med 1984; 310: 750-758
    CrossrefPubMedGoogle Scholar
  • 10 Detre KM, Takaro T, Hultgren H et al. Long-term mortality and morbidity results of the Veterans Administration randomized trial of coronary artery bypass surgery. Circulation 1985; 72: V84-89
    PubMedGoogle Scholar
  • 11 Frye RL, August P, Brooks MM et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515
    CrossrefPubMedGoogle Scholar
  • 12 Windecker S, Kolh P, Alfonso F et al. 2014 ESC / EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541-2619
    CrossrefPubMedGoogle Scholar
  • 13 Fihn SD, Gardin JM, Abrams J et al. 2012 ACCF / AHA / ACP / AATS / PCNA / SCAI / STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012; 60: e44-e164
    CrossrefPubMedGoogle Scholar
  • 14 Hillis LD, Smith PK, Anderson JL et al. 2011 ACCF / AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: e123-e210
    CrossrefPubMedGoogle Scholar
  • 15 Sechtem U. Is FAME 2 a breakthrough for PCI in stable coronary disease?. Clin Res Cardiol 2015; 104: 283-287
    CrossrefPubMedGoogle Scholar
  • 16 Ong P, Athanasiadis A, Hill S et al. Coronary microvascular dysfunction assessed by intracoronary acetylcholine provocation testing is a frequent cause of ischemia and angina in patients with exercise-induced electrocardiographic changes and unobstructed coronary arteries. Clin Cardiol 2014; 37: 462-467
    PubMedGoogle Scholar
  • 17 Mohr FW, Morice MC, Kappetein AP et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629-638
    CrossrefPubMedGoogle Scholar
  • 18 Wu C, Camacho FT, Zhao S et al. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann Thorac Surg 2013; 95: 1297-1305
    CrossrefPubMedGoogle Scholar
  • 19 Farkouh ME, Domanski M, Sleeper LA et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367: 2375-2384
    CrossrefPubMedGoogle Scholar
  • 20 Hage FG, Venkataraman R, Zoghbi GJ et al. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 2009; 53: 2129-2140
    CrossrefPubMedGoogle Scholar
  • 21 Rastan AJ, Walther T, Falk V et al. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery?. Circulation 2009; 120: S70-77
    CrossrefPubMedGoogle Scholar
  • 22 Garcia S, Sandoval Y, Roukoz H et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013; 62: 1421-1431
    CrossrefPubMedGoogle Scholar
  • 23 Farooq V, Serruys PW, Garcia-Garcia HM et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol 2013; 61: 282-294
    CrossrefPubMedGoogle Scholar
  • 24 Kurlansky PA, Traad EA, Dorman MJ et al. Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups. Ann Thorac Surg 2010; 90: 101-108
    CrossrefPubMedGoogle Scholar
  • 25 Lytle BW, Blackstone EH, Sabik JF et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004; 78: 2005-2012
    CrossrefPubMedGoogle Scholar
  • 26 Dorman MJ, Kurlansky PA, Traad EA et al. Bilateral internal mammary artery grafting enhances survival in diabetic patients: a 30-year follow-up of propensity score-matched cohorts. Circulation 2012; 126: 2935-2942
    CrossrefPubMedGoogle Scholar
  • 27 Tranbaugh RF, Dimitrova KR, Friedmann P et al. Coronary artery bypass grafting using the radial artery: clinical outcomes, patency, and need for reintervention. Circulation 2012; 126: S170-175
    CrossrefPubMedGoogle Scholar
  • 28 Hayward PA, Gordon IR, Hare DL et al. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial. J Thorac Cardiovasc Surg 2010; 139: 60-65
    CrossrefPubMedGoogle Scholar
  • 29 Shroyer AL, Grover FL, Hattler B et al. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 2009; 361: 1827-1837
    CrossrefPubMedGoogle Scholar
  • 30 Lamy A, Devereaux PJ, Prabhakaran D et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med 2012; 366: 1489-1497
    CrossrefPubMedGoogle Scholar
  • 31 Houlind K, Kjeldsen BJ, Madsen SN et al. On-pump versus off-pump coronary artery bypass surgery in elderly patients: results from the Danish on-pump versus off-pump randomization study. Circulation 2012; 125: 2431-2439
    CrossrefPubMedGoogle Scholar
  • 32 Diegeler A, Börgermann J, Kappert U et al. Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. N Engl J Med 2013; 368: 1189-1198
    CrossrefPubMedGoogle Scholar
  • 33 Kuss O, von Salviati B, Borgermann J. Off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses. J Thorac Cardiovasc Surg 2010; 140: 829-835
    CrossrefPubMedGoogle Scholar
  • 34 Polomsky M, He X, O’Brien SM, Puskas JD. Outcomes of off-pump versus on-pump coronary artery bypass grafting: Impact of preoperative risk. J Thorac Cardiovasc Surg 2013; 145: 1193-1198
    CrossrefPubMedGoogle Scholar
  • 35 Chowdhury R, White D, Kilgo P et al. Risk factors for conversion to cardiopulmonary bypass during off-pump coronary artery bypass surgery. Ann Thorac Surg 2012; 93: 1936-1941
    CrossrefPubMedGoogle Scholar
  • 36 Panoulas VF, Colombo A, Margonato A et al. Hybrid coronary revascularization: promising, but yet to take off. J Am Coll Cardiol 2015; 65: 85-97
    CrossrefPubMedGoogle Scholar
  • 37 Gasior M, Zembala MO, Tajstra M et al. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv 2014; 7: 1277-1283
    CrossrefPubMedGoogle Scholar